K132940 is an FDA 510(k) clearance for the ERCHONIA ALLAY. Classified as Powered Light Based Laser Non-thermal Instrument With Non-heating Effect For Adjunctive Use In Pain Therapy (product code NHN), Class II - Special Controls.
Submitted by Erchonia Medical, Inc. (Littleton, US). The FDA issued a Cleared decision on April 14, 2014 after a review of 207 days - an extended review cycle.
This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.5500 - the FDA physical medicine device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Physical Medicine review framework, consistent with the majority of Class II 510(k) submissions.
NCT01835743
Completed
Interventional
Industry-sponsored
Study of Low Level Laser Therapy to Treat Chronic Heel Pain Arising From Plantar Fasciitis
A Double-Blind, Placebo-Controlled Randomized Evaluation of the Effect of the Erchonia HP Scanner (HPS) Laser on Chronic Heel Pain
| Condition studied |
Plantar Fasciitis |
| Study design |
Parallel |
| Eligibility |
All sexes
· 18 Years+
|
| Principal investigator |
Michael Coughlin, M.D. |
| Sponsor |
Erchonia Corporation
(industry)
|
Started 2012-02-01
→
Primary completion 2012-05-01
→
Completed 2013-05-01
Primary outcome
Number of Participants Who Attained a Change of -30% or Greater in the VAS Score
Secondary outcome
Change in Heel Pain Score on the Visual Analog Scale (VAS)
View full study on ClinicalTrials.gov